iRhythm® Technologies Announces Leadership Transition
June 01, 2021 16:05 ET | Source: iRhythm iRhythm
President and CEO Michael Coyle Steps Down Due to Personal Matters
Douglas Devine to Serve as Interim CEO While Search for Permanent CEO is Conducted
SAN FRANCISCO, June 01, 2021 (GLOBE NEWSWIRE) iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that Mike Coyle has decided to resign from his position as President and Chief Executive Officer and a member of the Company’s Board of Directors, effective June 1, 2021, due to personal matters. Douglas Devine, the Company’s Chief Financial Officer, has assumed the role of interim CEO while a search for a permanent CEO is conducted. The iRhythm Board of Directors has formed a CEO search committee and has retained a leading executive search firm to assist in the search process.
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 1) Anika .